RACHEL GUNDERSON: Open Payments
NPI 1598037012 · ST. JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 34 payments from 12 companies in 2025. Trend: 2023 $420 · 2024 $747 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $223 |
| AstraZeneca Pharmaceuticals LP | 6 | $166 |
| Astellas Pharma US Inc | 3 | $63 |
| Boston Scientific Corporation | 2 | $41 |
| Novo Nordisk Inc | 2 | $34 |
| Lilly USA, LLC | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Amgen Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
Products named: BREZTRI, VRAYLAR, UBRELVY, Veozah, QULIPTA, Wegovy, JARDIANCE, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
